Levodopa Methyl Ester Hydrochloride

盐酸左旋多巴甲酯

Report date: 2023/02/21 15:07:43
NME

Base Information

Drug NameLevodopa Methyl Ester Hydrochloride
Drug Alias Name左旋多巴甲酯L-dopa-methylesterLevodopa-methylesterMelevodopaLevomet +[9
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionDopamine receptors agonists
TargetsDopamine receptors
Therapy Area/IndicationsParkinson Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusWithdrawn
Highest Status in ChinaN/A
Originator CompaniesChiesi Farmaceutici SPA
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesChiesi Farmaceutici SPA
Active IndicationsN/A
Inactive IndicationsParkinson Disease

Other Information

ATC CodeN04BA04
Related LinksWikipediaKEGG